Vesugen

Vesugen is a synthetic tripeptide bioregulator composed of lysine, glutamic acid, and aspartic acid. It was developed for research involving vascular tissue, endothelial function, and age-related changes in blood vessels. Experimental studies suggest that Vesugen may influence gene expression and cellular proliferation pathways associated with vascular endothelial maintenance.

Research has examined Vesugen’s effects on the proliferation-associated protein Ki-67, vascular aging, neuroplasticity, and broader biological-aging markers. A small human study also evaluated Vesugen in adults with age-related health conditions, but the available clinical evidence remains limited and should not be treated as proof of efficacy for any medical condition.